- Home
- MYRG vs CDTX Comparison
MYRG vs CDTX Comparison
Compare MYRG & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYRG
- CDTX
- Stock Information
- Founded
- MYRG 1891
- CDTX 2012
- Country
- MYRG United States
- CDTX United States
- Employees
- MYRG N/A
- CDTX N/A
- Industry
- MYRG Water Sewer Pipeline Comm & Power Line Construction
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYRG Industrials
- CDTX Health Care
- Exchange
- MYRG Nasdaq
- CDTX Nasdaq
- Market Cap
- MYRG 2.9B
- CDTX 2.8B
- IPO Year
- MYRG N/A
- CDTX 2015
- Fundamental
- Price
- MYRG $228.53
- CDTX $102.95
- Analyst Decision
- MYRG Buy
- CDTX Strong Buy
- Analyst Count
- MYRG 7
- CDTX 13
- Target Price
- MYRG $193.50
- CDTX $118.50
- AVG Volume (30 Days)
- MYRG 209.4K
- CDTX 986.8K
- Earning Date
- MYRG 10-29-2025
- CDTX 11-06-2025
- Dividend Yield
- MYRG N/A
- CDTX N/A
- EPS Growth
- MYRG 169.49
- CDTX N/A
- EPS
- MYRG 6.17
- CDTX N/A
- Revenue
- MYRG $3,514,140,000.00
- CDTX N/A
- Revenue This Year
- MYRG $7.49
- CDTX N/A
- Revenue Next Year
- MYRG $6.23
- CDTX N/A
- P/E Ratio
- MYRG $36.52
- CDTX N/A
- Revenue Growth
- MYRG N/A
- CDTX N/A
- 52 Week Low
- MYRG $97.72
- CDTX $12.54
- 52 Week High
- MYRG $228.16
- CDTX $121.21
- Technical
- Relative Strength Index (RSI)
- MYRG 67.72
- CDTX 57.26
- Support Level
- MYRG $216.93
- CDTX $93.60
- Resistance Level
- MYRG $222.40
- CDTX $107.00
- Average True Range (ATR)
- MYRG 8.07
- CDTX 5.83
- MACD
- MYRG 1.59
- CDTX -1.38
- Stochastic Oscillator
- MYRG 96.30
- CDTX 39.96
About MYRG MYR Group Inc.
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.